NCT01952392View on ClinicalTrials.gov

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

CompletedOBSERVATIONAL
Enrollment

4,992

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Acute Coronary Syndrome
Trial Locations (1)

Unknown

Research Site, Paris

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY